- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 1.77M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.24M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 18.77K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.69M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.74M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $11.05M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $8.23M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $10.55M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $6.01M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.21M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.03M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $794K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.64M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $794K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.66M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $11.28M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $8.59M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $11.34M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $8.67M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.61 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$162.30 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.61 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$162.30 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $361K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.64M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.05M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.05M |